PLoS ONE · 2014 · 71 citations · 48 references
PharmacyPharmacologyToxicologyNeurochemistryNeuropharmacologyNeurotoxicologyDopaminergic PharmacologyDrug-induced NeurotoxicityDrugs Of AbuseMonoamine NeurochemistryNeurochemical PharmacologyNeurotoxic MechanismsDopamine Receptor-mediated NeurotoxicityDopaminergic NeuronsDopaminergic PathwaysDopaminergic Side EffectsNeurotoxicityNeurotoxicity Of DrugsSerotonin Transporter PharmacologyTryptophan Hydroxylation
Mephedrone is a drug of abuse marketed as 'bath salts". There are discrepancies concerning its long-term effects. We have investigated the neurotoxicity of mephedrone in mice following different exposition schedules. Schedule 1: four doses of 50 mg/kg. Schedule 2: four doses of 25 mg/kg. Schedule 3: three daily doses of 25 mg/kg, for two consecutive days. All schedules induced, in some animals, an aggressive behavior and hyperthermia as well as a decrease in weight gain. Mephedrone (schedule 1) induced dopaminergic and serotoninergic neurotoxicity that persisted 7 days after exposition. At a lower dose (schedule 2) only a transient dopaminergic injury was found. In the weekend consumption pattern (schedule 3), mephedrone induced dopamine and serotonin transporter loss that was accompanied by a decrease in tyrosine hydroxylase and tryptophan hydroxylase 2 expression one week after exposition. Also, mephedrone induced a depressive-like behavior, as well as a reduction in striatal D2 density, suggesting higher susceptibility to addictive drugs. In cultured cortical neurons, mephedrone induced a concentration-dependent cytotoxic effect. Using repeated doses for 2 days in an elevated ambient temperature we evidenced a loss of frontal cortex dopaminergic and hippocampal serotoninergic neuronal markers that suggest injuries at nerve endings.
48
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Roger D. Porsolt, Guy Anton, N. Blavet et al. · European Journal of Pharmacology · 1978 · 3.1K citations